The North America Lab Automation Market was valued at $1039.8 Million in 2026 and projected to reach to $1400.2 Million by 2031, representing a compound annual growth rate of 7.6%. North America's lab automation market is poised for sustained expansion through 2031, driven by healthcare providers' focus on reducing operational costs and improving turnaround times.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America's lab automation market is valued at $1,039.8 million in 2026, expanding at a 7.6% CAGR to reach $1,400.2 million by 2031, outpacing the global growth rate of 6.6%.
The region benefits from cutting-edge healthcare facilities, robust diagnostic networks, and high-quality laboratory standards that accelerate lab automation adoption across clinical and research settings.
North America leads in implementing AI-driven analytics, cloud-based laboratory information systems, and integrated automation platforms, enhancing operational efficiency and data management capabilities.
Significant pharmaceutical and biotechnology R&D spending in the US and Canada drives demand for sophisticated automation solutions, supporting drug discovery, genomics, and personalized medicine initiatives.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SOFTWARE (Product) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.6% from 2026 to 2031 |
| Largest Segment | AUTOMATED WORKSTATIONS (Product) |
| Market Size Base Year (Billions) | ~USD 6.26 (2026) |
| Revenue Forecast (Billions) | ~USD 8.62 (2031) |
| Segments Covered | Application, Type, Product, End User |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|
| Country | 2025 size (native) |
|---|---|
| US | USD 3265.6 Million |
| Canada | USD 348.9 Million |
In 2026, North America's lab automation market is valued at $1,039.8 million USD.
North America's lab automation market is forecast to reach $1,400.2 million USD by 2031.
North America's lab automation market is expected to grow at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2031.
North America leads due to its advanced healthcare infrastructure, high technology adoption, significant R&D investments, and concentration of major pharmaceutical and biotech companies.
Key drivers include operational efficiency demands, cost reduction pressures, regulatory support, favorable reimbursement policies, and the need to improve diagnostic accuracy in clinical and research laboratories.
Four primary studies have been undertaken to size the lab automation market. Secondary research has been used to obtain preliminary data for the lab automation market and peer and parent markets. Data were collected from 3–5 secondary sources and validated by primary sources for assumptions and market sizing. Through top-down and bottom-up approaches, the overall market size was informed and further broken down, and data was triangulated for segment and subsegment sizing.
These included directories, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings, and investor presentations, among others. Through these sources, one can gain critical data about market leaders, how the industry is divided into sectors, and how technology varies from one industry level to another within lab automation.
Primary research consisted of interviews with supply- and demand-side stakeholders to obtain quantitative and qualitative insights. On the demand side, primary sources involved in the study included physicians, researchers, department heads, staff from diagnostic centers, hospital staff, and those attached to the research institutes, while on the supply side, it involved CEOs, area sales managers, territory and regional sales managers, and various other top executives of relevant companies. These direct meetings with people in key leadership positions helped validate assumptions arising from secondary research and bring them face-to-face so that any assumptions could also be directly questioned.
![]()
Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
This report used revenue-share analyses of major companies to determine the size of the global lab automation market. This was accomplished by identifying the major market participants and calculating their lab automation revenue using information gathered during the primary and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, primary research involved in-depth interviews with important thought leaders, including directors, CEOs, and important marketing executives.
Segmental revenues were computed using the revenue mapping of the leading solution/service providers to determine the worldwide market value. The following steps were engaged in this process

The above process has divided the lab automation market into several segments and subsegments. Then, data triangulation and the market segmentation process are conducted to confirm the accuracy of the data for each segment. Both factors and trends from the demand and supply sides were researched. Top-down and bottom-up approaches yield the outcome from the analysis of the Lab Automation market.
The lab automation market includes automated workstations, off-the-shelf automated work cells, robotics, automated storage & retrieval systems, and software that automates laboratory procedures to boost efficiency, productivity, and accuracy. It is integrated with devices to aid in complex operations, data collection, and repetitive procedures across life sciences, academic institutes, diagnostics, pharmaceutical research, and other labs. Drug discovery, diagnostics, proteomics, genomics, and microbiology are some of the most critical applications of lab automation solutions.
Product Analysis
Company Information
Geographic Analysis
Full forecast, segment splits, and company analysis for all Lab Automation Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report